Skip Navigation


JAC Advance Access originally published online on November 28, 2002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/1/202    most recent
dkg025v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Moyenuddin, M.
Right arrow Articles by Peacock, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moyenuddin, M.
Right arrow Articles by Peacock, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, 202-203
© 2003 The British Society for Antimicrobial Chemotherapy

Correspondence

Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin–dalfopristin combination therapy

Munshi Moyenuddin1, Christopher A. Ohl1, John C. Williamson2 and James E. Peacock1,*

1 Section on Infectious Diseases, Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157; 2 Department of Pharmacy, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA

Keywords: disseminated, oxacillin-resistant Staphylococcus aureus

The first 10% of the full text of this article appears below.

Sir,

We describe a case with oxacillin-resistant Staphylococcus aureus (ORSA) bacteraemia with associated polyarticular septic arthritis, soft-tissue abscesses, vertebral osteitis and discitis. Although the ORSA isolates were susceptible to vancomycin (VAN), bacteraemia, fever and leucocytosis persisted while on treatment with VAN, rifampicin and gentamicin but resolved with combination treatment of VAN and quinupristin–dalfopristin (Q-D).

In April 2002, a 67-year-old female with a history of gout presented to the emergency department (ED) with pain and swelling of the right great toe with . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
J. Brown and B. B Freeman III
Combining Quinupristin/Dalfopristin with Other Agents for Resistant Infections
Ann. Pharmacother., April 1, 2004; 38(4): 677 - 685.
[Abstract] [Full Text] [PDF]